AB 20. Mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease
Background: In patients with COPD, there is an evidence of platelet
activation due to chronic hypoxia and systemic inflammation. Aim
of the study was to evaluate Mean Platelet Volume (MPV) and
Platelet Distribution Width (PDW), markers of platelet activation, in
patients with Chronic Obstructive Pulmonary Disease (COPD), and
to investigate possible associations with pulmonary function testing
[Forced expiratory volume in 1 second (FEV1) and Forced vital capacity
(FVC)].
Patients and methods: Current smokers with stable COPD (n=85)
and smokers without airflow limitation (n=35) were included. To all
of them pulmonary function testing was performed and count of white
blood cells (WBC) platelets, as well as MPV and PDW were measured.
Results: In smokers with COPD, MPV was significantly higher (mean
value 10.563±1.531 vs. 9.956±1.046 fl, P<0.05) than in control group.
WBC was also significantly higher in patients with COPD than in
controls (9045.53±2664.34/μL vs. 7018.79±1989.74/μL, P<0.001). A
significant correlation between MPV and WBC in COPD patients was
revealed, especially in those at GOLD Stage III (r=0.475, P=0.012) and
IV (r=0.367, P=0.033). WBC count was correlated with FEV1/FVC
values (P=0.044). MPV did not correlate with any indices of COPD
severity.
Conclusions: In patients with COPD, MPV and WBC levels are
significantly correlated and are elevated in comparison to smokers with
normal pulmonary function. WBC count was negatively correlated with
FEV1/FVC values.